I will say this about NP: he said that a manufacturing deal was going to happen soon, and it did. Licensing may be more difficult when considering that have multiple offers, have to determine %s and possibly that the BPs making offers may be trying to get in on cancer indications as well.
Honestly, investors would be upset if NP had never mentioned possible licensing deals. They’d be posting all over the place. He mentioned it to let investors know that CYDY has offers and they’re working toward non-dilutive financing. That’s good enough for me even if he has to raise more money in the short term. The SP will rebound nicely.
Market Data 
Markets 
AI
